HIV-infected individuals are at increased risk of developing cerebral small vessel disease (CSVD). Myelin damage is a feature in CSVD, and can be quantified using myelin water imaging. In this work, we investigated if MWI can be used to quantify myelin related changes in white matter in an HIV cohort at risk of CSVD. Our results lend support to the use of MHI to track myelin related abnormalities in the white matter.
This abstract and the presentation materials are available to members only; a login is required.